Product Information
XELSTRYM 13.5 MG/9 HR PATCH is a brand product labeled by Noven Therapeutics, LLC, priced at $16.2931 per EA under NDC 68968021503. Its NADAC has been published 102 times since Jul 17, 2024.
Strength
13.5 mg/1
Manufacturer
Noven Therapeutics, LLCNDC
68968021503
Classification
Brand
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Last Updated
6/17/2026
Active Ingredients
DEXTROAMPHETAMINEApproval Type
New Drug (NDA)
FDA Application
NDA215401On Market Since
5/15/2023
Pharmacological Classes
Price Statistics
The NADAC for XELSTRYM 13.5 MG/9 HR PATCH has been published 102 times since Jul 17, 2024, and over the history we have for it it has risen 4.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.2931 per EA |
|---|---|
| All-time high | $16.3585 (May 14, 2025) |
| All-time low | $15.5744 (Aug 21, 2024) |
| 52-week high | $16.3252 |
| 52-week low | $16.2868 |
| Median price | $16.3089 |
| Average price | $16.1463 |
| Largest weekly change | +5.0% (Jan 1, 2025) |
| Weeks tracked | 102 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the DEXTROAMPHETAMINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of XELSTRYM 13.5 MG/9 HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for XELSTRYM 13.5 MG/9 HR PATCH, manufactured by Noven Therapeutics, LLC, is $16.2931 per EA (NDC 68968021503), effective Jun 24, 2026.
How has the price of XELSTRYM 13.5 MG/9 HR PATCH changed over time?
Over the history we have for it, the NADAC for XELSTRYM 13.5 MG/9 HR PATCH has risen 4.5%. It has been tracked across 102 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for XELSTRYM 13.5 MG/9 HR PATCH?
Since Jul 17, 2024, the NADAC for XELSTRYM 13.5 MG/9 HR PATCH has ranged from a low of $15.5744 (Aug 21, 2024) to a high of $16.3585 (May 14, 2025), with a median of $16.3089 per EA.
Are there cheaper alternatives to XELSTRYM 13.5 MG/9 HR PATCH?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of XELSTRYM 13.5 MG/9 HR PATCH, so no direct lower-cost alternative is listed.
Who manufactures XELSTRYM 13.5 MG/9 HR PATCH?
XELSTRYM 13.5 MG/9 HR PATCH (NDC 68968021503) is labeled by Noven Therapeutics, LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification